NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 67 filers reported holding NOVELION THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $26,000 | -7.1% | 36,428 | 0.0% | 0.01% | +60.0% |
Q2 2019 | $28,000 | -37.8% | 36,428 | 0.0% | 0.01% | -61.5% |
Q1 2019 | $45,000 | +45.2% | 36,428 | 0.0% | 0.01% | +30.0% |
Q4 2018 | $31,000 | -71.3% | 36,428 | 0.0% | 0.01% | -50.0% |
Q3 2018 | $108,000 | -19.4% | 36,428 | 0.0% | 0.02% | -39.4% |
Q2 2018 | $134,000 | +5.5% | 36,428 | 0.0% | 0.03% | +13.8% |
Q1 2018 | $127,000 | +11.4% | 36,428 | 0.0% | 0.03% | -21.6% |
Q4 2017 | $114,000 | -55.5% | 36,428 | 0.0% | 0.04% | -56.5% |
Q3 2017 | $256,000 | -23.8% | 36,428 | 0.0% | 0.08% | -15.0% |
Q2 2017 | $336,000 | -14.1% | 36,428 | 0.0% | 0.10% | -28.6% |
Q1 2017 | $391,000 | – | 36,428 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|